Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Vasc Surg Venous Lymphat Disord ; 8(4): 601-609, 2020 07.
Article in English | MEDLINE | ID: mdl-32089497

ABSTRACT

OBJECTIVE: To evaluate the impact of three treatment modalities, superficial truncal vein ablation, perforator vein ablation, and deep venous stenting on venous leg ulcer (VLU) healing, as well as their cumulative effect on ulcer healing, in an attempt to establish the best algorithm for the treatment of chronic and recalcitrant VLUs. METHODS: Multicenter retrospective cohort study using a standardized database to evaluate patients with chronic venous ulcers treated between January 2013 and December 2017. RESULTS: Eight-hundred thirty-two consecutive patients with VLU were identified at 11 centers in the United States. All patients were initially managed with wound care and compression for at least 2 months. Compression and wound care management alone, used in 187 patients, led to ulcer healing in 75% of patients by 36 months. Ulcer recurrence in patients managed without surgery at 6, 12, and 24 months was 3%, 5% and 15%, respectively. Five hundred twenty-eight patients underwent ablation of incompetent superficial veins, and 344 of those also underwent incompetent perforator ablation. Patients who underwent truncal vein ablation alone had an ulcer healing rate of 51% at 36 months. Patients who received both superficial and perforator ablation were significantly younger, and had a 17% improvement in healing at 36 months (68% vs 51%, respectively), but there was no impact of combined superficial and perforator ablations on ulcer recurrence rates. One hundred thirty-four patients had stenosis of one of more lower extremity deep veins and 95 (71%) underwent endovenous stenting. Ulcer healing and recurrence rates for those who underwent stent placement alone was 77% and 27%, respectively, at 36 months. Patients who underwent deep venous stenting and ablation of both incompetent truncal and perforator veins had an ulcer healing rate of 87% at 36 months and ulcer recurrence of 26% at 24 months. CONCLUSIONS: This study demonstrates that correction of superficial truncal vein reflux, as well as deep vein stenosis, both contribute to healing of VLU. Patients who fail to heal their VLU after superficial and perforator ablation should have the iliocaval system imaged to identify hemodynamically significant stenoses or occlusions amenable to stenting, which facilitates venous ulcer healing even in patients with large ulcers.


Subject(s)
Catheter Ablation , Endovascular Procedures , Laser Therapy , Saphenous Vein/surgery , Sclerotherapy , Varicose Ulcer/therapy , Wound Healing , Aged , Catheter Ablation/adverse effects , Chronic Disease , Databases, Factual , Endovascular Procedures/adverse effects , Endovascular Procedures/instrumentation , Female , Humans , Laser Therapy/adverse effects , Male , Middle Aged , Recurrence , Retrospective Studies , Saphenous Vein/diagnostic imaging , Saphenous Vein/physiopathology , Sclerotherapy/adverse effects , Stents , Time Factors , Treatment Outcome , United States , Varicose Ulcer/diagnostic imaging , Varicose Ulcer/physiopathology
2.
Ann Vasc Surg ; 34: 106-10, 2016 Jul.
Article in English | MEDLINE | ID: mdl-27116905

ABSTRACT

BACKGROUND: Percutaneous endovascular aneurysm repair (PEVAR) continues to evolve. Device profiles continue to decline, further reducing the physiological insult of the procedure. Anesthesia, however, has not evolved with a large proportion of patients continuing to receive general anesthesia for their increasingly less invasive procedures. We report on a novel anesthetic technique providing outstanding anesthesia in patients undergoing PEVAR in an outpatient setting. The total anesthesia used was remarkably cost effective. METHODS: Six patients underwent PEVAR in an outpatient setting. The patients received moderate intravenous (IV) access sedation using versed and fentanyl in combination with bilateral ilioinguinal nerve blocks. Patients received 25 mL bilaterally of 0.5% bupivicaine with epinephrine. All patients were American Society of Anesthesiologists class III. None received central venous access, arterial, or urinary catheters. Standard noninvasive monitoring was used. A board-certified anesthesiologist was present at all times during the procedures. RESULTS: All patients underwent successful repair. Average cost per case for anesthetic supplies averaged around $7.00. The fentanyl dose ranged from 100 to 200 µg with an average dose of 130 µg. Versed dose ranged from 2 to 3 mg with an average dose of 2.4 mg. No patient required conversion to general anesthesia. Postoperative pain relief was excellent. Two patients required pain medication before discharge. Two patients required oral narcotic analgesic the night of discharge. No patients required narcotics after that time. CONCLUSIONS: Bilateral ilioinguinal nerve block, when combined with moderate IV sedation allows outstanding anesthesia for patients undergoing PEVAR. This novel combination has not been reported previously. The technique provides safe, effective, care for of a subset of patients not requiring general anesthesia. It offers a greatly reduced cost when compared with general anesthesia. Additional benefits include prolonged pain relief perioperatively as well as potentially decreasing the physiologic and cognitive effects seen with general anesthesia.


Subject(s)
Aneurysm/surgery , Blood Vessel Prosthesis Implantation , Conscious Sedation , Endovascular Procedures , Hypnotics and Sedatives/administration & dosage , Midazolam/administration & dosage , Nerve Block , Aged , Ambulatory Surgical Procedures , Analgesics, Opioid/administration & dosage , Aneurysm/diagnostic imaging , Blood Vessel Prosthesis Implantation/adverse effects , Blood Vessel Prosthesis Implantation/economics , Conscious Sedation/adverse effects , Conscious Sedation/economics , Cost Savings , Cost-Benefit Analysis , Drug Costs , Endovascular Procedures/adverse effects , Endovascular Procedures/economics , Fentanyl/administration & dosage , Humans , Hypnotics and Sedatives/adverse effects , Hypnotics and Sedatives/economics , Male , Midazolam/adverse effects , Midazolam/economics , Middle Aged , Nerve Block/adverse effects , Nerve Block/economics , Pain, Postoperative/etiology , Pain, Postoperative/prevention & control , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...